AbbVie revenue trends

In 1H17, AbbVie (ABBV) reported revenues of around $13.5 million, compared to $12.4 million in 1H16. In 1Q17 and 2Q17, AbbVie reported revenues of around $6.5 million and $6.9 million, respectively, compared to $5.9 million and $6.5million in 1Q16 and 2Q16. Humira and Imbruvica primarily pushed revenue growth in 1H17.

In 1H17, AbbVie reported operating earnings of around $5.09 billion, compared to $4.67 billion in 1H16. In 1H17, AbbVie reported net earnings of around $3.6 billion, compared to $3.0 billion in 1H16.

How AbbVie Performed in 1H17

The chart above shows the revenue curve for AbbVie from 1Q16 to 2Q17 and analysts’ estimates from 3Q17 to 4Q18. To learn more about AbbVie’s 2Q17 performance, see How Did AbbVie Perform in 2Q17?

In 1H17, AbbVie reported basic earnings per share (or EPS) of around $2.26, compared to $1.82 million in 1H16. In 1Q17 and 2Q17, the company reported basic EPS of $1.07 and $1.20, respectively, compared to $0.83 and $0.99 in 1Q16 and 1Q17.

In 1H17, AbbVie reported total current assets of around $16.96 billion, compared to $16.19 billion in 1H16.

1H17 expenses

In 1H17, AbbVie reported its cost of products sold at around $3.1 billion, compared to $2.8 billion in 1H16. In 1H17, AbbVie reported SG&A (selling, general, and administrative) expenses and R&D (research and development) expenses of around $2.87 billion and $2.36 billion, respectively, compared to $2.82 billion and $2.07 billion in 1H16.

AbbVie’s revenue growth could boost the iShares Core S&P 500 ETF (IVV). AbbVie makes up about ~0.69% of IVV’s total portfolio holdings.

Latest articles

President Trump tweeted about his plans to meet with Apple (AAPL) CEO Tim Cook. It's possible that they could discuss Apple’s US manufacturing plans.

WeWork is gearing up for an IPO. On Wednesday, the company made its IPO filing with the SEC public and expects to garner $3.5 billion from its IPO.

After FCC Chairman Ajit Pai recommended the approval of the T-Mobile–Sprint merger, Representative David Cicilline urged the FCC to allow public comment.

Cresco Labs (CRLBF) is set to report its Q2 earnings on August 21 after the market closes. The company's stock fell 5.3% yesterday.

Cannabis stocks mostly traded in positive territory today. Supreme Cannabis (FIRE) and Aurora Cannabis (ACB) rose about 9.5% and 5.5%, respectively.

NVIDIA (NVDA) stock soared 6% in today’s trading session as its Q2 earnings for fiscal 2020 beat estimates. However, its guidance missed estimates.